Trade AYTU stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Aytu BioPharma, Inc. (AYTU) is trading at US$1.99, down 2.93% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$25.44M. Over the past 52 weeks, AYTU has traded between US$1.65 and US$3.07. On Syfe you can trade AYTU with $0 commission and add it to your watchlist.
| Previous close | US$2.05 |
|---|---|
| Market cap | US$25.44M |
| P/E ratio | 12.81 |
| 52-week range | US$1.65 – US$3.07 |
| Volume | 61.57K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Aytu BioPharma, Inc.
Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Denver, CO.
Year: 2008
Aytu BioPharma, Inc. (AYTU) stock is trading at US$1.99, -2.93% from the previous close of US$2.05.
The market cap for Aytu BioPharma, Inc. (AYTU) stock is approximately US$25.44M.
The price-to-earnings ratio for Aytu BioPharma, Inc. (AYTU) is 12.81, based on the latest reported earnings.
The 52-week high for Aytu BioPharma, Inc. (AYTU) stock is US$3.07.
The 52-week low for Aytu BioPharma, Inc. (AYTU) stock is US$1.65.
Aytu BioPharma, Inc. (AYTU) does not currently pay a dividend.
Stay on top of AYTU
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
